In Brief: Novoste
This article was originally published in The Gray Sheet
Executive Summary
Novoste: Begins clinicals of its Beta-Cath intracoronary beta irradiation catheter system for the prevention of post-angioplasty restenosis at Emory University Hospital in Atlanta. Intended for use immediately following balloon angioplasty, the application of beta radiation to the treatment site is expected to inhibit restenosis. FDA approved an investigational device exemption for the study in July 1995 ("The Gray Sheet" Aug. 7, 1995, In Brief)...